Overview
APLS market data
Price History
APLS price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for APLS. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Cantor Fitzgerald Suspends Neutral Rating on Apellis PharmaceuticalsBenzinga · May 15, 2026, 12:35 PM
Why Is Biogen Stock Falling Thursday?Benzinga · May 14, 2026, 4:15 PM
Biogen Completes Acquisition of Apellis PharmaceuticalsBenzinga · May 14, 2026, 1:15 PM
8-K filing — Apellis Pharmaceuticals, Inc. (APLS)SEC EDGAR · May 14, 2026, 12:45 PM
Biogen Stock Gains Despite Extended FDA Review For Alzheimer's TherapyBenzinga · May 8, 2026, 4:05 PM